• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

RECAM: A New and Improved, Computerized Causality Assessment Tool for DILI Diagnosis.

作者信息

Hayashi Paul H, Lucena M Isabel, Fontana Robert J

机构信息

Division of Hepatology and Nutrition, Food and Drug Administration, Silver Spring, Maryland, USA.

Servicio de Farmacologia Clinica, Instituto de Investigacion Biomedica de Malaga-IBIMA, Hospital Universitario Virgen de la Victoria, Universidad de Malaga, Malaga Spain. CIBERehd, Madrid, Spain.

出版信息

Am J Gastroenterol. 2022 Sep 1;117(9):1387-1389. doi: 10.14309/ajg.0000000000001836. Epub 2022 May 25.

DOI:10.14309/ajg.0000000000001836
PMID:35973138
Abstract
摘要

相似文献

1
RECAM: A New and Improved, Computerized Causality Assessment Tool for DILI Diagnosis.RECAM：一种用于药物性肝损伤诊断的全新且经过改进的计算机化因果关系评估工具。
Am J Gastroenterol. 2022 Sep 1;117(9):1387-1389. doi: 10.14309/ajg.0000000000001836. Epub 2022 May 25.
2
Validation of the revised electronic version of RUCAM for diagnosis of DILI in Chinese patients.修订版电子RUCAM在中国患者药物性肝损伤诊断中的验证
Hepatol Commun. 2024 Mar 11;8(4). doi: 10.1097/HC9.0000000000000235. eCollection 2024 Apr 1.
3
Causality assessment for suspected DILI during clinical phases of drug development.药物研发临床阶段疑似药物性肝损伤的因果关系评估。
Drug Saf. 2014 Nov;37 Suppl 1(Suppl 1):S47-56. doi: 10.1007/s40264-014-0185-4.
4
Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score.避免药物性肝损伤（DILI）在一个老年住院队列中，使用更新的 RUCAM 评分评估因果关系的病例。
BMC Geriatr. 2020 Sep 14;20(1):346. doi: 10.1186/s12877-020-01732-3.
5
Highlights of the drug-induced liver injury literature for 2021.2021 年药物性肝损伤文献亮点。
Expert Rev Gastroenterol Hepatol. 2022 Aug;16(8):767-785. doi: 10.1080/17474124.2022.2101996. Epub 2022 Jul 22.
6
Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.经 Roussel Uclaf 因果关系评估方法评估的 3312 例药物性肝损伤病例中的排名前位药物。
Expert Opin Drug Metab Toxicol. 2018 Nov;14(11):1169-1187. doi: 10.1080/17425255.2018.1539077. Epub 2018 Oct 29.
7
Causality assessment in drug-induced liver injury.药物性肝损伤的因果关系评估
Semin Liver Dis. 2009 Nov;29(4):348-56. doi: 10.1055/s-0029-1240003. Epub 2009 Oct 13.
8
Drug-induced Liver Injury in Pediatrics.儿科药物性肝损伤。
J Pediatr Gastroenterol Nutr. 2022 Oct 1;75(4):391-395. doi: 10.1097/MPG.0000000000003535. Epub 2022 Jun 21.
9
Assessment of drug-induced liver injury in clinical practice.临床实践中药物性肝损伤的评估
Fundam Clin Pharmacol. 2008 Apr;22(2):141-58. doi: 10.1111/j.1472-8206.2008.00566.x.
10
Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury.不同药物性肝损伤因果关系评估量表之间的一致性。
Clin Drug Investig. 2018 Mar;38(3):211-218. doi: 10.1007/s40261-017-0601-5.

引用本文的文献

1
Dapagliflozin-Associated Hepatotoxicity With a Positive Rechallenge.达格列净相关肝毒性伴再激发试验阳性
ACG Case Rep J. 2025 Aug 4;12(8):e01799. doi: 10.14309/crj.0000000000001799. eCollection 2025 Aug.
2
Propafenone-Induced Cholestatic Liver Injury: When Diagnosis Does Not Skip a Beat.普罗帕酮所致胆汁淤积性肝损伤：诊断时需分秒必争。
GE Port J Gastroenterol. 2024 Oct 18;32(3):212-220. doi: 10.1159/000541557. eCollection 2025 Jun.
3
Acetazolamide-Induced Liver Injury: A Case Report and Literature Review.乙酰唑胺所致肝损伤：一例报告及文献综述
Cureus. 2025 Mar 13;17(3):e80536. doi: 10.7759/cureus.80536. eCollection 2025 Mar.
4
Drug-Induced Liver Injury Associated With Emerging Cancer Therapies.与新兴癌症治疗相关的药物性肝损伤
Liver Int. 2025 Feb;45(2):e70002. doi: 10.1111/liv.70002.
5
Atorvastatin-Induced Liver Injury With Concurrent Rhabdomyolysis After a Positive Rechallenge.再次激发试验阳性后出现的阿托伐他汀诱导的肝损伤并发横纹肌溶解症
ACG Case Rep J. 2024 Dec 30;12(1):e01570. doi: 10.14309/crj.0000000000001570. eCollection 2025 Jan.
6
Pirfenidone-induced liver injury, a case report of a rare idiosyncratic reaction.吡非尼酮所致肝损伤，一例罕见特异质性反应的病例报告。
Ther Adv Drug Saf. 2024 Sep 14;15:20420986241270866. doi: 10.1177/20420986241270866. eCollection 2024.
7
Methods for causality assessment of idiosyncratic drug-induced liver injury.特异质性药物性肝损伤的因果关系评估方法。
Liver Int. 2025 Mar;45(3):e16083. doi: 10.1111/liv.16083. Epub 2024 Aug 21.
8
Rituximab-Associated Liver Toxicity Without Known Viral Reactivation.利妥昔单抗相关的无已知病毒再激活的肝毒性
Cureus. 2024 Jul 11;16(7):e64331. doi: 10.7759/cureus.64331. eCollection 2024 Jul.
9
Acute Liver Injury Caused by Cyclophosphamide in a Patient With Factor VIII Deficiency: A Rare Presentation.一名患有VIII因子缺乏症的患者因环磷酰胺导致急性肝损伤：一种罕见的表现。
Cureus. 2024 Mar 7;16(3):e55717. doi: 10.7759/cureus.55717. eCollection 2024 Mar.
10
Complementary and alternative medicines and liver disease.补充和替代医学与肝脏疾病。
Hepatol Commun. 2024 Apr 3;8(4). doi: 10.1097/HC9.0000000000000417. eCollection 2024 Apr 1.